AAV's and uses thereof
US10035825B2 · kind B2 · utility
16Cited by
36References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 27, 2016 |
| Grant date | Jul 31, 2018 |
| Priority date | — |
| Expiry date | Jan 27, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14145
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention in some aspects relates to recombinant adeno-associated viruses having distinct tissue targeting capabilities. In some aspects, the invention relates to gene transfer methods using the recombinant adeno-associate viruses. In some aspects, the invention relates to isolated AAV capsid proteins and isolated nucleic acids encoding the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.